The Department of Veterans Affairs (VA) awarded a 5-year Blanket Purchase Agreement (BPA) to Neogenomics Laboratories, Inc. to provide specialized reference laboratory testing services, including genetic testing, flow cytometry, and diagnostic pathology, in support of veteran healthcare across the VA medical network. The $75,000 BPA enables the VA to directly order required diagnostic testing and analysis on an as-needed basis to support personalized medicine and care for veterans. Additionally,...
This is a Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 1 (VISN1) of the U.S. Department of Veterans Affairs (VA) to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory. The contract, valued at a ceiling of $3,076,515.00, is for the provision of Fluorescence in situ hybridization (FISH) testing services to support VA medical centers and healthcare systems within VISN1 over a 5-year period from April 2024 to March 2029. The contract...
This Blanket Purchase Agreement (BPA) is a single-award federal contract vehicle administered by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17 to procure cancer diagnostic testing services from MdxHealth, Inc., a for-profit healthcare company. The BPA calls for MdxHealth to provide its MDXHEALTH GPS molecular diagnostic services, which utilize genetic and epigenetic biomarkers to support personalized diagnosis and treatment for various cancers...
The Blanket Purchase Agreement (BPA) is a federal contract indefinite delivery vehicle (IDV) awarded by the Veterans Integrated Service Network 19 (VISN 19), a division of the U.S. Department of Veterans Affairs (VA). The single-award BPA, with a ceiling value of $123,503.57, was awarded to Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated, to provide anatomic pathology testing services. The contract has an ultimate completion date of August 30, 2029. Under this BPA, Ameripath...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Exact Sciences Corp, through its Exact Sciences Laboratories, LLC division, for the provision of GENOMIC HEALTH GENETIC TESTING services. The total ceiling value of the BPA is $919,774.30, with the initial award on October 1, 2020 and a period of performance through September 30, 2025. The contract was placed against the General Services Administration (GSA)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Neogenomics Laboratories, Inc. a blanket purchase agreement to provide immunohistochemical genetic testing and staining services in support of the Rocky Mountain Regional VA Medical Center. Over five consecutive one-year ordering periods from July 2020 through June 2025, call orders valued from $38,758 to $90,000 have been placed against this agreement to procure these diagnostic...
This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, a medical technology company specializing in cancer diagnostic testing services. The BPA has a ceiling value of $497,370.24 and a period of performance through August 31, 2025. Under this contract, Exact Sciences Laboratories, LLC, a division of Exact Sciences Corporation, will provide medical laboratory testing and analysis services, including gene expression...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network (VISN) 22 awarded a single-award Blanket Purchase Agreement (BPA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for Oncotype genetic testing services. The BPA has a ceiling value of $970,352 and a period of performance from February 2023 through February 2028. Under this IDV, the VA can order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis at...
This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA), to Quest Diagnostics Incorporated, a large diagnostic information services provider. The BPA has a ceiling value of $655,178.76 and a period of performance from July 1, 2025 to December 31, 2025. The BPA is intended to provide 6-month bridge coverage for specialized genetic and esoteric laboratory testing services for VISN 2 South, a...
The Department of the Army Medical Command has awarded Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory, a 5-year Blanket Purchase Agreement (BPA) to provide NEOTYPE SOLID TUMOR TESTING AND REPEAT FISH TESTING at Tripler Army Medical Center in Hawaii. The BPA has a potential value of $1,000,000.00 and covers the period from April 1, 2019 to March 11, 2024. Through this single-award IDV, Neogenomics will furnish specialized cancer testing and diagnostic services,...